Consumer expectations about zinc supplementation may not align with physiological reality. Research published in the American Journal of Clinical Nutrition demonstrates that higher supplement doses do not deliver proportionally greater zinc absorption. The culprit is ZIP4, a saturable transporter on intestinal cells that reaches functional capacity around 11mg of net absorbed zinc per dose, regardless of intake amount.
Fractional absorption declines sharply as dose increases—from 73% at 2mg to just 37% at 30mg. This means a 50% dose increase from 20mg to 30mg adds only 0.2mg of additional absorbed zinc. The same saturation principle governs other micronutrient transporters, suggesting that megadose supplementation strategies may offer diminishing returns across multiple nutrients.
For clinicians and consumers, this finding underscores the importance of evidence-based dosing rather than assumptions about dose-response relationships. Read the full article on GMJ Newsroom.
Was this article helpful?
